Hindustan Bio Sciences Limited (BOM:532041)

Market Cap	96.36M +34.5%
Revenue (ttm)	11.35M +40.1%
Net Income	1.48M +326.3%
EPS	0.16 +376.1%
Shares Out	10.25M
PE Ratio	60.38
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,644
Average Volume	7,491
Open	9.85
Previous Close	9.42
Day's Range	8.97 - 9.85
52-Week Range	5.00 - 10.32
Beta	-0.91
RSI	66.46
Earnings Date	May 29, 2026

About Hindustan Bio Sciences

Hindustan Bio Sciences Limited engages in the manufacturing and sale of pharmaceutical products in India. The company offers tablets, capsules, drops, externels, and syrups. It is also involved in marketing a nephrology product, recombinant human Erythropotien; and trading of drugs and medicines. In addition, the company exports its products. Hindustan Bio Sciences Limited was incorporated in 1991 and is based in Hyderabad, India.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1991
• Employees: 2
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 532041

Financial Performance

In fiscal year 2025, Hindustan Bio Sciences's revenue was 8.13 million, a decrease of -22.75% compared to the previous year's 10.53 million. Earnings were 1.01 million, an increase of 74.83%.